P16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma

被引:33
|
作者
Platt, G
Carbone, A
Mittnacht, S
机构
[1] Inst Canc Res, Chester Beatty Labs, Ctr Mol & Cell Biol, London SW3 6JB, England
[2] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Div Pathol, Aviano, Italy
关键词
p16INK4a; retinoblastoma (Rb); Kaposi's sarcoma associated herpes virus (KSHV); human herpesvirus 8 (HHV8); primary effusion lymphoma (PEL);
D O I
10.1038/sj.onc.1205360
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Kaposi's Sarcoma associated Herpes virus (KSHV) encodes two genes with the potential to affect the activity of the retinoblastoma protein (Rb). Open reading frame (orf) 72 encodes a D type cyclin (kcyc) that can elicit p16INK4a resistant cdk activity and orf73 encodes the latency associated nuclear antigen (LNA) that can bind Rb and neutralize E2F regulation. This indicates that, like papilloma and adenovirus associated malignancies, those associated with KSHV are defective with respect to their Rb pathway. To address this we investigated whether KSHV associated primary effusion lymphoma (PEL) derived cell lines are resistant to growth inhibition by p16INK4a. We provide evidence that ectopic expression of p16INK4a in these cells causes an Rb dependent G1 cell cycle block. Importantly, endogenous p16INK4a expression is not detected in six PEL derived cell lines and four primary PEL samples and examination of the p16INK4a locus shows deletion in two out of six and hypermethylation in four out of six PEL lines. Treatment of the latter with the demethylating agent 5'-aza-2' deoxycytidine leads to re-expression of p16INK4a protein. Taken together these results suggest that p16INK4a loss may be a cellular change frequently associated with PEL. They furthermore argue that despite the presence of KSHV DNA and expression of a latent gene program Rb function is intact in PEL.
引用
收藏
页码:1823 / 1831
页数:9
相关论文
共 50 条
  • [1] p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma
    Georgina Platt
    Antonino Carbone
    Sibylle Mittnacht
    [J]. Oncogene, 2002, 21 : 1823 - 1831
  • [2] Loss of p16Ink4a
    Weitzman J.B.
    [J]. Genome Biology, 2 (1):
  • [3] Somatic p16INK4a loss accelerates melanomagenesis
    Monahan, K. B.
    Rozenberg, G. I.
    Krishnamurthy, J.
    Johnson, S. M.
    Liu, W.
    Bradford, M. K.
    Horner, J.
    DePinho, R. A.
    Sharpless, N. E.
    [J]. ONCOGENE, 2010, 29 (43) : 5809 - 5817
  • [4] Somatic p16INK4a loss accelerates melanomagenesis
    K B Monahan
    G I Rozenberg
    J Krishnamurthy
    S M Johnson
    W Liu
    M K Bradford
    J Horner
    R A DePinho
    N E Sharpless
    [J]. Oncogene, 2010, 29 : 5809 - 5817
  • [5] Methylation of p16INK4A in primary gynecologic malignancy
    Wong, YF
    Chung, TKH
    Cheung, TH
    Nobori, T
    Yu, AL
    Yu, J
    Batova, A
    Lai, KWH
    Chang, AMZ
    [J]. CANCER LETTERS, 1999, 136 (02) : 231 - 235
  • [6] p16INK4A -: alterations in primary angiosarcoma of the liver
    Tannapfel, A
    Weihrauch, M
    Benicke, M
    Uhlmann, D
    Hauss, J
    Wrbitzky, R
    Wittekind, C
    [J]. JOURNAL OF HEPATOLOGY, 2001, 35 (01) : 62 - 67
  • [7] Hyperemethylation of p16INK4a is associated with cervical neoplasia
    Ju, Woong
    Kang, Eun Ji
    Lee, Sa Ra
    Lee, Shi Nae
    Kim, Seung Cheol
    Choi, Joong Sub
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3476S - 3476S
  • [8] P16INK4a promoter hypermethylation is frequently found in multiple myeloma and is associated with silencing of the p16INK4a gene.
    Willer, A
    Krämer, A
    Schultheis, B
    Saussele, S
    Reiter, A
    Hastka, J
    Hochhaus, A
    Hegenbart, U
    Goldschmidt, H
    Hehlmann, R
    [J]. BLOOD, 1998, 92 (10) : 258A - 258A
  • [9] Deletion in p16INK4a and loss of p16 expression in human skin primary and metastatic melanoma cells
    Zhang, H
    Rosdahl, I
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 24 (02) : 331 - 335
  • [10] Inactivation of tumor suppressor genes p15INK4b and p16INK4a in primary cutaneous b cell lymphoma
    Child, FJ
    Scarisbrick, JJ
    Calonje, E
    Orchard, G
    Russell-Jones, R
    Whittaker, SJ
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 118 (06) : 941 - 948